GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PCI Biotech Holding ASA (LTS:0JGL) » Definitions » E10

PCI Biotech Holding ASA (LTS:0JGL) E10 : kr-3.23 (As of Jun. 2023)


View and export this data going back to 2008. Start your Free Trial

What is PCI Biotech Holding ASA E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

PCI Biotech Holding ASA's adjusted earnings per share data for the three months ended in Jun. 2023 was kr-0.154. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr-3.23 for the trailing ten years ended in Jun. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of PCI Biotech Holding ASA was -4.60% per year. The lowest was -5.80% per year. And the median was -5.20% per year.

As of today (2024-06-11), PCI Biotech Holding ASA's current stock price is kr2.82. PCI Biotech Holding ASA's E10 for the quarter that ended in Jun. 2023 was kr-3.23. PCI Biotech Holding ASA's Shiller PE Ratio of today is .


PCI Biotech Holding ASA E10 Historical Data

The historical data trend for PCI Biotech Holding ASA's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PCI Biotech Holding ASA E10 Chart

PCI Biotech Holding ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.04 -2.09 -1.95 -3.07 -

PCI Biotech Holding ASA Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.91 -3.07 -3.32 -3.23 -

Competitive Comparison of PCI Biotech Holding ASA's E10

For the Biotechnology subindustry, PCI Biotech Holding ASA's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PCI Biotech Holding ASA's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PCI Biotech Holding ASA's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where PCI Biotech Holding ASA's Shiller PE Ratio falls into.



PCI Biotech Holding ASA E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PCI Biotech Holding ASA's adjusted earnings per share data for the three months ended in Jun. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=-0.154/130.4000*130.4000
=-0.154

Current CPI (Jun. 2023) = 130.4000.

PCI Biotech Holding ASA Quarterly Data

per share eps CPI Adj_EPS
201309 -0.507 96.400 -0.686
201312 -0.686 96.600 -0.926
201403 -0.716 97.300 -0.960
201406 -0.729 97.500 -0.975
201409 -0.743 98.500 -0.984
201412 -0.917 98.600 -1.213
201503 -0.473 99.200 -0.622
201506 -0.306 100.100 -0.399
201509 -0.431 100.600 -0.559
201512 -0.390 100.900 -0.504
201603 -0.446 102.500 -0.567
201606 -0.576 103.800 -0.724
201609 -0.576 104.200 -0.721
201612 -0.408 104.400 -0.510
201703 -0.399 105.000 -0.496
201706 -0.260 105.800 -0.320
201709 -0.410 105.900 -0.505
201712 -0.640 106.100 -0.787
201803 -0.580 107.300 -0.705
201806 -0.280 108.500 -0.337
201809 -0.330 109.500 -0.393
201812 -0.050 109.800 -0.059
201903 -0.610 110.400 -0.721
201906 -0.710 110.600 -0.837
201909 -0.380 111.100 -0.446
201912 -0.682 111.300 -0.799
202003 0.120 111.200 0.141
202006 -0.780 112.100 -0.907
202009 -0.570 112.900 -0.658
202012 -0.710 112.900 -0.820
202103 -0.640 114.600 -0.728
202106 -0.490 115.300 -0.554
202109 -0.570 117.500 -0.633
202112 -1.250 118.900 -1.371
202203 -0.617 119.800 -0.672
202206 -0.394 122.600 -0.419
202209 -0.290 125.600 -0.301
202212 -0.180 125.900 -0.186
202303 -0.160 127.600 -0.164
202306 -0.154 130.400 -0.154

Add all the adjusted EPS together and divide 10 will get our e10.


PCI Biotech Holding ASA  (LTS:0JGL) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


PCI Biotech Holding ASA E10 Related Terms

Thank you for viewing the detailed overview of PCI Biotech Holding ASA's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


PCI Biotech Holding ASA (LTS:0JGL) Business Description

Traded in Other Exchanges
Address
Ullernchausseen 64, Oslo, NOR, N-0379
PCI Biotech Holding ASA is a biopharmaceutical company. It focuses on developing and commercializing therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The PCI technology works by inducing light-triggered endosomal release. PCI is applied to three distinct anticancer paradigms; fimaCHEM which is an enhancement of chemotherapeutics for localized treatment of cancer, fimaVACC which is T-cell induction technology for therapeutic vaccination, and fimaNAc which is nucleic acid therapeutics delivery. Its therapeutic product candidate is the photosensitizer fimaporfin (Amphinex) which can unlock the intracellular capsules where active compounds are trapped.

PCI Biotech Holding ASA (LTS:0JGL) Headlines

No Headlines